Long Term Prospective Study of Tai Chi Intervention to Delay the Progression of Subjective Cognitive Impairment

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age60-75
SponsorRuijin Hospital

About this trial

This study evaluates the effects of 3 years-Tai Chi exercise intervention on cognitive function in subjects with subjective cognitive impairment (SCI). Participants will be randomized into the Tai chi training group and the control group.

Eligibility criteria

Qualifiers

Male and female participants aged 60 to 75 years (inclusive) at the time of screening;

Willing and able to give informed consent by GCP and local guidance;

Meets the diagnostic criteria for subjective cognitive impairment (SCI) and the following criteria

Subjective decline in memory, rather than other domains of cognition

Disqualifiers

Cognitive impairment caused by other reasons (for example) cerebrovascular disease, central nervous system infection, Creutzfeldt-Jakob disease, Huntington's disease, Parkinson's disease, dementia with Lewy bodies, trauma, other physical and chemical factors (drugs, alcohol, CO, etc.), important physical diseases (hepatic encephalopathy, pulmonary encephalopathy, etc.), brain tumor, endocrine diseases (thyroid disease, parathyroid disease), and vitamin deficiency or any other cause of dementia;

Abnormal folate, thyroid, and/or vitamin B12 values that cannot be corrected before baseline visit;

Major structural brain disease as judged by central MRI Diagnostic Imaging Review Team (eg, ischemic infarcts, subdural hematoma, hemorrhage, hydrocephalus, brain tumors, multiple subcortical ischemic lesions. or a single lesion in a critical region [eg, thalamus]). Mild white matter changes without clinical significance and no more than 2 lacunar infarcts are permitted;

Geriatric Depression Scale-15(GDS-15) total score > 7 at screening;

Trial design

Treatments tested in this trial

  • Tai chi training
  • Group activity

Treatment groups

134 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Ruijin Hospital

Lead sponsor

Zhangjiagang Aoyang Hospital of Jiangsu Province

Collaborator